Published in

Hindawi, BioMed Research International, (2013), p. 1-6, 2013

DOI: 10.1155/2013/460546

Hindawi, BioMed Research International, (2014), p. 1-1

DOI: 10.1155/2014/437910

Links

Tools

Export citation

Search in Google Scholar

Strategies for Imaging Androgen Receptor Signaling Pathway in Prostate Cancer: Implications for Hormonal Manipulation and Radiation Treatment

Journal article published in 2013 by Giovanni Luca Gravina, G. Giovanni Luca, Gravina Giovanni Luca, Claudio Festuccia, Pierluigi Bonfili, Mario Di Staso, Pietro Franzese, Valeria Ruggieri, Vladimir M. Popov, Vincenzo Tombolini ORCID, Carlo Masciocchi, Eleonora Carosa, Andrea Lenzi, Emmanuele A. Jannini ORCID, Ernesto Di Cesare
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Prostate cancer (Pca) is a heterogeneous disease; its etiology appears to be related to genetic and epigenetic factors. Radiotherapy and hormone manipulation are effective treatments, but many tumors will progress despite these treatments. Molecular imaging provides novel opportunities for image-guided optimization and management of these treatment modalities. Here we reviewed the advances in targeted imaging of key biomarkers of androgen receptor signaling pathways. A computerized search was performed to identify all relevant studies in Medline up to 2013. There are well-known limitations and inaccuracies of current imaging approaches for monitoring biological changes governing tumor progression. The close integration of molecular biology and clinical imaging could ease the development of new molecular imaging agents providing novel tools to monitor a number of biological events that, until a few years ago, were studied by conventional molecular assays. Advances in translational research may represent the next step in improving the oncological outcome of men with Pca who remain at high risk for systemic failure. This aim may be obtained by combining the anatomical properties of conventional imaging modalities with biological information to better predict tumor response to conventional treatments.